Shail M Govani1, Akbar K Waljee2, Ryan W Stidham1, Peter Dr Higgins1. 1. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. 2. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA ; Center for Clinical Management Research, US Department of Veteran's Affairs, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Clostridium difficile infection (CDI) is an increasingly common cause of inpatient mortality. Vitamin D deficiency is associated with more aggressive CDI. We aimed to determine if average annual ultraviolet light (UV) exposure was associated with mortality in patients with CDI. METHODS: We used the US National Inpatient Sample (NIS) from 2004-2011 to assess the mortality risk in patients with a diagnosis of CDI (as per ICD-9CM 008.45). Annual average state UV exposure was assigned to each hospitalization. Logistic regression was used to determine the effects of UV exposure on mortality, controlling for age, gender, race and other comorbidities. RESULTS: During the study period, there were 2.61 million hospitalizations with a diagnosis of CDI. The mortality rate was 9.0%. In univariate analysis, the odds ratio (OR) of inpatient mortality for the UV index was 0.97 (95% CI 0.95-0.99; p = 0.008) per unit of UV exposure. In a multivariable model adjusting for age, gender, race, Charlson-Deyo index, season and coexisting inflammatory bowel disease, the UV index remained a protective predictor, with an OR of 0.94 (95% CI 0.92-0.96; p < 0.001). In the multivariate model, a seasonal effect was also present, with the highest risk of inpatient mortality in the period from January to March (OR 1.11; 95% CI 1.08-1.14) and the lowest risk, from July to September (OR 0.95; 95% CI 0.92-0.98). CONCLUSIONS: An increase in UV exposure index is associated with a reduced risk of inpatient mortality in patients with CDI. A seasonal effect is also present, with the highest risk of death during winter months. Further studies exploring the role of UV light in CDI are necessary.
BACKGROUND:Clostridium difficileinfection (CDI) is an increasingly common cause of inpatient mortality. Vitamin D deficiency is associated with more aggressive CDI. We aimed to determine if average annual ultraviolet light (UV) exposure was associated with mortality in patients with CDI. METHODS: We used the US National Inpatient Sample (NIS) from 2004-2011 to assess the mortality risk in patients with a diagnosis of CDI (as per ICD-9CM 008.45). Annual average state UV exposure was assigned to each hospitalization. Logistic regression was used to determine the effects of UV exposure on mortality, controlling for age, gender, race and other comorbidities. RESULTS: During the study period, there were 2.61 million hospitalizations with a diagnosis of CDI. The mortality rate was 9.0%. In univariate analysis, the odds ratio (OR) of inpatient mortality for the UV index was 0.97 (95% CI 0.95-0.99; p = 0.008) per unit of UV exposure. In a multivariable model adjusting for age, gender, race, Charlson-Deyo index, season and coexisting inflammatory bowel disease, the UV index remained a protective predictor, with an OR of 0.94 (95% CI 0.92-0.96; p < 0.001). In the multivariate model, a seasonal effect was also present, with the highest risk of inpatient mortality in the period from January to March (OR 1.11; 95% CI 1.08-1.14) and the lowest risk, from July to September (OR 0.95; 95% CI 0.92-0.98). CONCLUSIONS: An increase in UV exposure index is associated with a reduced risk of inpatient mortality in patients with CDI. A seasonal effect is also present, with the highest risk of death during winter months. Further studies exploring the role of UV light in CDI are necessary.
Authors: Lillias H Maguire; Mingyang Song; Lisa E Strate; Edward L Giovannucci; Andrew T Chan Journal: Clin Gastroenterol Hepatol Date: 2013-08-15 Impact factor: 11.382
Authors: Hamed Khalili; Edward S Huang; Ashwin N Ananthakrishnan; Leslie Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan Journal: Gut Date: 2012-01-11 Impact factor: 23.059
Authors: Tressia C Hing; Samantha Ho; David Q Shih; Ryan Ichikawa; Michelle Cheng; Jeremy Chen; Xinhua Chen; Ivy Law; Robert Najarian; Ciaran P Kelly; Richard L Gallo; Stephan R Targan; Charalabos Pothoulakis; Hon Wai Koon Journal: Gut Date: 2012-07-03 Impact factor: 23.059
Authors: Shail M Govani; Peter D R Higgins; Ryan W Stidham; Scott J Montain; Akbar K Waljee Journal: J Crohns Colitis Date: 2014-11-26 Impact factor: 9.071
Authors: Scott J Montain; Susan M McGraw; Matthew R Ely; Tyson L Grier; Joseph J Knapik Journal: BMC Musculoskelet Disord Date: 2013-04-12 Impact factor: 2.362
Authors: Bisundev Mahato; Tiffany M N Otero; Carrie A Holland; Patrick T Giguere; Ednan K Bajwa; Carlos A Camargo; Sadeq A Quraishi Journal: J Intensive Care Date: 2016-06-17